Obligation UBSL 0% ( CH1136718751 ) en USD

Société émettrice UBSL
Prix sur le marché 100 %  ▲ 
Pays  Suisse
Code ISIN  CH1136718751 ( en USD )
Coupon 0%
Echéance 08/10/2024 - Obligation échue



Prospectus brochure de l'obligation UBS (London Branch) CH1136718751 en USD 0%, échue


Montant Minimal 1 000 USD
Montant de l'émission 3 500 000 USD
Description détaillée UBS (London Branch) est une succursale de la banque suisse UBS, offrant une large gamme de services financiers aux particuliers, aux entreprises et aux institutions financières au Royaume-Uni et au-delà.

L'Obligation émise par UBSL ( Suisse ) , en USD, avec le code ISIN CH1136718751, paye un coupon de 0% par an.
Le paiement des coupons est semestriel et la maturité de l'Obligation est le 08/10/2024











USD Autocall Conditional Coupon Barrier Reverse Convertible linked to worst of PJSC
MMC Norilsk Nickel (ADR), PJSC LUKOIL (ADR), Sberbank Rossii PAO (ADR) and Gazprom
(PAO) (ADR)
Expiration Date: 1 October 2024
Issue Size: USD 3,500,000 (with reopening clause)
Issue Price: 100% (percentage quotation) as of Issue Date
Issuer: UBS AG, Zurich and Basel, Switzerland, acting through its London Branch
LEI Code: BFM8T61CT2L1QCEMIK50



The Issuer has issued structured products in securitized form (the ''Product'') in accordance with the terms and conditions
set out in this prospectus (the ''Prospectus'').

The Issuer has the possibility to increase the number of Units at any time during the lifetime of this Product. In the event
of an increase an additional prospectus will be prepared.

Application has been made to list the Products on the Official List of the Luxembourg Stock Exchange and to trade them
on the EURO MTF Market of that exchange. This Prospectus constitutes a prospectus for the purpose of the
Luxembourg law dated July, 16th 2019 on prospectuses for securities.

This Prospectus does not qualify as a prospectus published in accordance with the requirements of the EU Prospectus
Regulation (Regulation (EU) 2017/1129). This Prospectus may only be used for the purpose for which it has been
published.

Nobody is authorised to give information other than that contained in this Prospectus and the documents referred to
therein and which are made available for inspection by the public.

The Issuer does not intent to provide any post-issuance information.

The information sourced from a third party has been accurately reproduced and that no facts have been omitted which
would render the reproduced information inaccurate or misleading.

Issuer accepts responsibility for the information contained in this Prospectus and declares that, to its best knowledge, the
information contained in the prospectus is accurate and does not omit any material circumstances.

Issuer declares that there has been no material change in the prospects and financial position of the Issuer since the
date of the last financial information incorporated by reference into the Prospectus.





Date
13 October 2021







USD Autocall Conditional Coupon Barrier Reverse
Convertible
Linked to worst of PJSC MMC Norilsk Nickel (ADR), PJSC LUKOIL (ADR), Sberbank
Rossii PAO (ADR) and Gazprom (PAO) (ADR)


Issued by UBS AG, Zurich and Basel, Switzerland, acting through its London Branch


Cash settled; Kick In observation at expiry

SSPA Product Type: Conditional Coupon Barrier Reverse Convertible (1260, Auto-

Callable) Valor: 113671875 / ISIN: CH1136718751 / WKN: UH3ENJ / CFI: DEEFRB /

Common Code: 239776477





Final Terms
Prospectus Exempt Offer
This document (Final Terms) will not be filed with a Swiss reviewing body or any other competent authority according to article 45
of the Swiss Federal Act on Financial Services (FinSA). This Product may only be offered in accordance with the Selling Restrictions
as set out below.

The Product does not represent a participation in any of the collective investment schemes pursuant to article 7 et seq. of the
Swiss Federal Act on Collective Investment Schemes (CISA) and thus does not require an authorisation of the Swiss Financial Market
Supervisory Authority (FINMA). Therefore, investors in this Product are not eligible for the specific investor protection under the CISA.
Moreover, investors in this Product bear the issuer risk. Furthermore, this Product does not benefit from any depositor protection
under article 37a of the Swiss Federal Act on Banks and Savings Banks (Banking Act) or other forms of deposit insurance under any
other law as might be applicable to this Product.

Information on Underlying


Underlying(k)
Reference Level
Strike Level
Kick In Level
PJSC MMC Norilsk Nickel (ADR)
USD 30.24
USD 30.24
USD 24.19
Bloomberg: MNOD LI / ISIN: US55315J1025 / Valor: 29777450 / RIC:
(Official closing price of the
(100% of the Reference
(80% of the Reference
NKELyq.L
Underlying on the Fixing
Level)
Level)
Date)
PJSC LUKOIL (ADR)
USD 95.42
USD 95.42
USD 76.34
Bloomberg: LKOD LI / ISIN: US69343P1057 / Valor: 30132053 / RIC:
(Official closing price of the
(100% of the Reference
(80% of the Reference
LKOHyq.L
Underlying on the Fixing
Level)
Level)
Date)
Sberbank Rossii PAO (ADR)
USD 18.54
USD 18.54
USD 14.832
Bloomberg: SBER LI / ISIN: US80585Y3080 / Valor: 13215571 / RIC:
(Official closing price of the
(100% of the Reference
(80% of the Reference
SBNCyq.L
Underlying on the Fixing
Level)
Level)
Date)
Gazprom (PAO) (ADR)
USD 9.936
USD 9.936
USD 7.949
Bloomberg: OGZD LI / ISIN: US3682872078 / Valor: 1002318 / RIC:
(Official closing price of the
(100% of the Reference
(80% of the Reference
GAZPq.L
Underlying on the Fixing
Level)
Level)
Date)
Early Redemption
Additional
Early Redemption
PJSC MMC Norilsk
LUKOIL (ADR)
Sberbank (ADR)
Gazprom (ADR)
Observation Date(j)/
Amount(j)/ Final
Level/ Redemption
Nickel (ADR)
Underlying(k=2)
Underlying(k=3)
Underlying(k=4)
Expiration Date
Additional Amount
Level
Underlying(k=1)
j=1
277.5 USD
(100% of the
USD 30.24
USD 95.42
USD 18.54
USD 9.936
Reference Level)
j=2
346.88 USD
(100% of the
USD 30.24
USD 95.42
USD 18.54
USD 9.936
Reference Level)
j=3
416.25 USD
(100% of the
USD 30.24
USD 95.42
USD 18.54
USD 9.936
Reference Level)
j=4
485.63 USD
(100% of the
USD 30.24
USD 95.42
USD 18.54
USD 9.936
Reference Level)
j=5
555 USD
(100% of the
USD 30.24
USD 95.42
USD 18.54
USD 9.936
Reference Level)
Contact:
UBS AG, P.O. Box, 8098 Zürich
Private Investors: Please contact your client advisor or send an email to [email protected]
Internet:
www.ubs.com/keyinvest
Banks and Intermediaries: +41-44-239 76 76*
Investors outside of Switzerland should consult their local client advisors
Please note that calls made to the numbers marked with an asterisk (*) may be recorded. Should you call one of these numbers, we shall assume that you consent to this business practice.



2/8
Valor: 113671875 / ISIN: CH1136718751 / WKN: UH3ENJ / Common Code: 239776477
Final Terms


Early Redemption
Additional
Early Redemption
PJSC MMC Norilsk
LUKOIL (ADR)
Sberbank (ADR)
Gazprom (ADR)
Observation Date(j)/
Amount(j)/ Final
Level/ Redemption
Nickel (ADR)
Underlying(k=2)
Underlying(k=3)
Underlying(k=4)
Expiration Date
Additional Amount
Level
Underlying(k=1)
j=6
624.38 USD
(100% of the
USD 30.24
USD 95.42
USD 18.54
USD 9.936
Reference Level)
j=7
693.75 USD
(100% of the
USD 30.24
USD 95.42
USD 18.54
USD 9.936
Reference Level)
j=8
763.13 USD
(100% of the
USD 30.24
USD 95.42
USD 18.54
USD 9.936
Reference Level)
Expiration Date
832.5 USD
(100% of the
USD 30.24
USD 95.42
USD 18.54
USD 9.936
Reference Level)

Product Details

Security Numbers
Valor: 113671875 / ISIN: CH1136718751 / WKN: UH3ENJ / CFI: DEEFRB / Common Code:
239776477
Issue Size
USD 3,500,000 (with reopening clause)
Denomination / Nominal Amount
USD 1,000
Issue Price
100% (percentage quotation)
Redemption Currency
USD
Quoting Type
Secondary market prices are quoted in percentage and dirty; accrued Additional Amount
is included in the price.

Dates

Launch Date
01 October 2021
Fixing Date
01 October 2021
Initial Payment Date (Issue Date)
08 October 2021
Last Trading Date
01 October 2024
Expiration Date
01 October 2024 (subject to market disruption event provisions)
Maturity Date
08 October 2024 (subject to market disruption event provisions)

Early Redemption

Early Redemption Observation
Early Redemption
Early Redemption
Early Redemption
Dates / Early Redemption Payment
Observation Date(j)
Observation Date
Payment Date
Dates
/ Early Redemption

Payment Date

(j)

j=1
03 October 2022
11 October 2022


j=2
03 January 2023
10 January 2023

j=3
03 April 2023
10 April 2023

j=4
03 July 2023
11 July 2023


j=5
02 October 2023
10 October 2023

j=6
02 January 2024
09 January 2024


j=7
02 April 2024
09 April 2024

j=8
01 July 2024
09 July 2024


(In case of a market disruption the next following Underlying Calculation Date shall be the
Early Redemption Observation Date for the affected Underlying only.
Contact:
UBS AG, P.O. Box, 8098 Zürich
Private Investors: Please contact your client advisor or send an email to [email protected]
Internet:
www.ubs.com/keyinvest
Banks and Intermediaries: +41-44-239 76 76*
Investors outside of Switzerland should consult their local client advisors
Please note that calls made to the numbers marked with an asterisk (*) may be recorded. Should you call one of these numbers, we shall assume that you consent to this business practice.



3/8
Valor: 113671875 / ISIN: CH1136718751 / WKN: UH3ENJ / Common Code: 239776477
Final Terms


If any of these Early Redemption Observation Dates is not an Underlying Calculation Date,
the next following Underlying Calculation Date shall be the Early Redemption Observation
Date for all Underlyings.)
Early Redemption Event
An Early Redemption Event is deemed to have occurred on any Early Redemption
Observation Date(j) if the Reference Price of all Underlyings on the respective Early
Redemption Observation Date(j) is equal to or higher than the respective Early
Redemption Level as reasonably determined by the Calculation Agent.
In this case, the Product shall automatically be early redeemed by the Issuer on the Early
Redemption Payment Date at the Early Redemption Amount per Product.
Early Redemption Amount per
Nominal Amount + Additional Amount(j)
Product

Redemption

If no Early Redemption has occurred, the investor is entitled to receive from the Issuer an amount in the Redemption Currency on
the Maturity Date, according to the following scenarios:
Scenario 1
If a Kick In Event has not occurred and
1) If the Expiration Price of all Underlyings is equal to or higher than the respective
Redemption Level, the Redemption Amount per Product shall be the sum of the Nominal
Amount and the Final Additional Amount.
2) If the Expiration Price of any Underlying is lower than the respective Redemption
Level, the Redemption Amount per Product shall be the Nominal Amount.
Scenario 2
If a Kick In Event has occurred and
1) If the Expiration Price of all Underlyings is equal to or higher than the respective
Redemption Level, the Redemption Amount per Product shall be the sum of the Nominal
Amount and the Final Additional Amount.
2) If the Expiration Price of any Underlying is lower than the respective Redemption
Level, the investor will receive the Expiration Value.
Kick In Observation Date
Expiration Date
Kick In Event
A Kick In Event shall be deemed to occur if on the Kick In Observation Date, the Expiration
Price of any Underlying quoted by the Relevant Exchange is lower than the respective Kick
In Level, as reasonably determined by the Calculation Agent.
Expiration Value


Relevant Underlying
The Underlying(k) with the lowest performance, as determined and calculated by the
Calculation Agent pursuant to the following formula:

Expiration Price
The Reference Price of the Underlying on the Expiration Date.
Reference Price
Specified Price per unit of the Underlying, stated in the relevant Currency, and published
by the Relevant Exchange.
Underlying: PJSC MMC Norilsk Nickel (ADR)
(Bloomberg Ticker: MNOD LI)
Specified Price: official closing price
Relevant Exchange: LONDON STOCK EXCHANGE, THE
Currency: USD
Underlying: PJSC LUKOIL (ADR)
(Bloomberg Ticker: LKOD LI)
Specified Price: official closing price
Relevant Exchange: LONDON STOCK EXCHANGE, THE
Currency: USD
Contact:
UBS AG, P.O. Box, 8098 Zürich
Private Investors: Please contact your client advisor or send an email to [email protected]
Internet:
www.ubs.com/keyinvest
Banks and Intermediaries: +41-44-239 76 76*
Investors outside of Switzerland should consult their local client advisors
Please note that calls made to the numbers marked with an asterisk (*) may be recorded. Should you call one of these numbers, we shall assume that you consent to this business practice.



4/8
Valor: 113671875 / ISIN: CH1136718751 / WKN: UH3ENJ / Common Code: 239776477
Final Terms


Underlying: Sberbank Rossii PAO (ADR)
(Bloomberg Ticker: SBER LI)
Specified Price: official closing price
Relevant Exchange: LONDON STOCK EXCHANGE, THE
Currency: USD
Underlying: Gazprom (PAO) (ADR)
(Bloomberg Ticker: OGZD LI)
Specified Price: official closing price
Relevant Exchange: LONDON STOCK EXCHANGE, THE
Currency: USD


General Information

Issuer
UBS AG, Zurich and Basel, Switzerland, acting through its London Branch
Issuer Rating
Aa3 Moody's / A+ S&P's / AA- Fitch
Issuer Supervisory Authority
Swiss Financial Market Supervisory Authority (FINMA). London Branch additionally

Financial Conduct Authority (FCA) and Prudential Regulation Authority (PRA). Jersey

Branch additionally Jersey Financial Services Commission (JFSC).
Lead Manager
UBS AG, Zurich (UBS Investment Bank)
Calculation Agent
UBS AG, London Branch
Paying Agent
UBS Switzerland AG
Relevant Exchange
PJSC MMC Norilsk Nickel (ADR): LONDON STOCK EXCHANGE, THE

LUKOIL (ADR): LONDON STOCK EXCHANGE, THE

Sberbank (ADR): LONDON STOCK EXCHANGE, THE

Gazprom (ADR): LONDON STOCK EXCHANGE, THE
Listing
Euro MTF Market of the Luxembourg Stock Exchange
Secondary Market
The Issuer or the Lead Manager, as applicable, intends, under normal market conditions,

to provide bid and/or offer prices for this Product on a regular basis. However, the Issuer or

the Lead Manager, as applicable, makes no firm commitment to provide liquidity by means

of bid and/or offer prices for this Product, and assumes no legal obligation to quote any

such prices or with respect to the level or determination of such prices.

Daily price indications will be available on Reuters/Bloomberg , SIX Financial Information

and www.ubs.com/keyinvest.
Trading Hours
09:00 - 17:30 (CET)
Banking Days
New York
Banking Day Convention
Where any date is used in conjunction with the term "Banking Day Convention", an

adjustment will be made if that date would otherwise fall on a day that is not a Banking

Day, so that the date will be the first following day that is a Banking Day. Investors shall

not be entitled to further interest or other payments in respect of such delay.
Underlying Calculation Date
The Underlying Calculation Date means each day, on which the Relevant Exchange is

open for trading and the price of the respective Underlying is determined in accordance

with the relevant rules.
Minimum Investment
USD 1,000 (subject to Selling Restrictions)
Minimum Trading Lot
USD 1,000
Status
Unsecured / Unsubordinated
Clearing System
SIX SIS, Euroclear, Clearstream (registered as intermediated securities with SIX SIS AG, in

Switzerland)
Form of Deed
Uncertificated Securities
Governing Law / Jurisdiction
Swiss / Zurich
Contact:
UBS AG, P.O. Box, 8098 Zürich
Private Investors: Please contact your client advisor or send an email to [email protected]
Internet:
www.ubs.com/keyinvest
Banks and Intermediaries: +41-44-239 76 76*
Investors outside of Switzerland should consult their local client advisors
Please note that calls made to the numbers marked with an asterisk (*) may be recorded. Should you call one of these numbers, we shall assume that you consent to this business practice.



5/8
Valor: 113671875 / ISIN: CH1136718751 / WKN: UH3ENJ / Common Code: 239776477
Final Terms


Product / Security
One Autocall Conditional Coupon Barrier Reverse Convertible is equivalent to one (1)
"Product" / "Security". "Products" / "Securities", wherever used herein shall be construed
to mean integral multiples of the same, subject to the Issue Size.
Adjustments
The terms of the Product may be subject to adjustments during its lifetime. Detailed
information on such adjustments is to be found in the Product Documentation. For
clients outside of the United Kingdom, any changes with regard to the terms of this
Product shall be published at www.ubs.com/keyinvest.

Tax Treatment Switzerland

Swiss Transfer Stamp Duty
The product qualifies as a taxable security (bond). In principle secondary market
transactions are subject to Swiss Stamp Duty.
Swiss Income Tax
For Swiss tax purposes this product is qualified as a combination of an option and a
bond, where the majority of the return is in the form of a discount or of one payment
on redemption date (IUP). For private investors resident in Switzerland the increase of the
bond floor at sale* or redemption* respectively is subject to income tax. However, any
gain derived from the option (if an option is included in the product) is for such investors
considered as capital gain and is not subject to income tax.
* For products which are not denominated in Swiss Francs, the bond floor has to be
converted into Swiss Francs at the prevailing exchange rate at sale or redemption and at
purchase.
If the product carries negative interest: If the product carries a negative interest at issuance,
these investors can pursuant to the practice of the Swiss Federal Tax Administration neither
set negative interest off against interest income nor deduct negative interest from other
taxable income.
Swiss Withholding Tax
This product is not subject to the Swiss Issuer Withholding Tax.
The tax information only provides a general overview over the Swiss tax consequences linked to this product based on the tax
laws and the practice of the tax administration at the time of issue. Tax laws and the practice of tax administrations may change,
possibly with retroactive effect.

Significant Risks for Investors

Investors in this Product should be experienced investors and familiar with both derivative products and the financial markets.
Potential investors should understand the risks associated with an investment in the Product and shall only reach an investment
decision after careful considerations with their legal, tax, financial and other advisors of (i) the suitability of an investment in the
Product in the light of their own particular financial, fiscal and other circumstances (ii) the information set out in this document
and (iii) the Underlying(s).
In addition to the market risk with regard to the development of the Underlying, each investor bears the general risk that
the financial situation of the Issuer could deteriorate ("Issuer Risk"). The Products constitute immediate, unsecured and
unsubordinated obligations of the Issuer, which, particularly in case of insolvency of the Issuer, rank pari passu with each and all
other current and future unsecured and unsubordinated obligations of the Issuer, with the exception of those that have priority due
to mandatory statutory provisions. The general assessment of the Issuer's creditworthiness may affect the value of the Products.
This assessment generally depends on the ratings assigned to the Issuer or its affiliated companies by rating agencies such as
Moody's, Fitch and Standard & Poor's. The Issuer Rating indicated in this document reflects the situation at the time of issuance
and may be subject to change. The actual Issuer Rating at any given time can be seen on the Issuer's website (www.ubs.com)
under "Investor Relations".
In addition to the risk factors below, further risk factors are set out in the UBS Swiss Base Prospectus for the Issuance
of Securities.

Product Specific Risks

Loss Potential
Investors may lose some or all of the investment as they are fully exposed to the
performance of the Relevant Underlying.
Capital Protection (at Expiry)
None
Risk Potential in comparison to a
The Kick In Level limits the risk exposure compared to a direct investment. However, once
direct investment in the Underlying
a Kick In Event has occured, the risk potential is similar as with a direct investment in the
Relevant Underlying.
Contact:
UBS AG, P.O. Box, 8098 Zürich
Private Investors: Please contact your client advisor or send an email to [email protected]
Internet:
www.ubs.com/keyinvest
Banks and Intermediaries: +41-44-239 76 76*
Investors outside of Switzerland should consult their local client advisors
Please note that calls made to the numbers marked with an asterisk (*) may be recorded. Should you call one of these numbers, we shall assume that you consent to this business practice.



6/8
Valor: 113671875 / ISIN: CH1136718751 / WKN: UH3ENJ / Common Code: 239776477
Final Terms


Issuer Call right
None, but an automatic Early Redemption may occur
Stop Loss Event
None
Extraordinary termination risk
The Product contains terms and conditions that allow the Issuer to terminate and redeem
the Product prior to the Maturity Date. In case of such extraordinary termination, the
Issuer shall pay to the investors an extraordinary termination amount as determined by
the Calculation Agent which is usually equivalent to the market value of the Product.
Potential investors should note that the extraordinary termination amount may deviate
from and may be considerably below the amount which would be payable pursuant to
the final redemption provisions on the Maturity Date. Investors are not entitled to request
any further payments on the Product after the termination date.
Adjustment risk
Potential investors should be aware that it cannot be excluded that certain events occur or
certain measures are taken (by parties other than the Issuer) in relation to the Underlying(s)
which can lead to changes to the Underlying(s) or its concept (e.g. corporate events of
a company whose shares constitute an Underlying, market disruption events or other
circumstances affecting normal activities). In the case of the occurrence of such events
or measures, the Issuer and/or the Calculation Agent are entitled to effect adjustments
according to the Product Documentation. Such adjustments might have a negative impact
on the value of the Product.
Illiquidity risk in secondary market The Issuer or the Lead Manager, as applicable, intends, under normal market conditions,
to provide bid and/or offer prices for this Product on a regular basis. However, the Issuer
or the Lead Manager, as applicable, makes no firm commitment to provide liquidity by
means of bid and/or offer prices for this Product, and assumes no legal obligation to quote
any such prices or with respect to the level or determination of such prices.
Potential investors therefore should not rely on the ability to sell this Product at a specific
time or at a specific price. Potential investors should note that prices quoted typically
include a spread and therefore may deviate from the market value of the Product. In special
market situations, where the Issuer is completely unable to enter into hedging transactions,
or where such transactions are very difficult to enter into, the spread between the bid
and offer prices in the secondary market may be temporarily expanded, in order to limit
the economic risks of the Issuer. Hence, investors might sell at a price considerably lower
than the actual price of the Product at the time of its sale. By selling the Product in the
secondary market investors may receive less than the capital invested.
In case of a secondary market transaction, there is a possibility that costs, including taxes,
related to or in connection with the Product may arise for investors that are not paid by
the Issuer or imposed by the Issuer.
Market Disruption risk
Investors are exposed to market disruption events (such as trading disruption, exchange
disruption and early closure of the relevant exchange), which could have an impact on the
redemption amount through delay in payment, change in value or suspension of trading
in the Product in the secondary market. For a detailed description of such events and their
effects please refer to the Product Documentation.
Withholding tax
Investors in this Product should note that any payment under this Product may be subject
to withholding tax (such as, inter alia, Swiss Withholding Tax, and/or withholding related
to FATCA or 871(m) of the US Tax Code). Any payments due under this Product are
net of such tax. Please refer to the Product Documentation for detailed information. If
the Issuer is required to withhold any amount pursuant to Section 871(m) or FATCA of
the U.S. Tax Code, the Issuer will not be required to pay additional amounts with respect
to the amount so withheld.

Important Information

The information herein is communicated by UBS AG and/or its affiliates ("UBS"). UBS may from time to time, as principal or
agent, have positions in, or may buy or sell, or make a market in any securities, currencies, financial instruments or other assets
underlying the Product to which this document relates. UBS may provide investment banking and/or other services to and/or have
officers who serve as directors of the companies referred to in this document. UBS's trading and/or hedging activities related to
this Product may have an impact on the price of the underlying asset(s) and may affect the likelihood that any relevant barrier(s)
is/are crossed. UBS has policies and procedures designed to minimise the risk that officers and employees are influenced by any
conflicting interest or duty and that confidential information is improperly disclosed or made available.
Contact:
UBS AG, P.O. Box, 8098 Zürich
Private Investors: Please contact your client advisor or send an email to [email protected]
Internet:
www.ubs.com/keyinvest
Banks and Intermediaries: +41-44-239 76 76*
Investors outside of Switzerland should consult their local client advisors
Please note that calls made to the numbers marked with an asterisk (*) may be recorded. Should you call one of these numbers, we shall assume that you consent to this business practice.



7/8
Valor: 113671875 / ISIN: CH1136718751 / WKN: UH3ENJ / Common Code: 239776477
Final Terms


In certain circumstances UBS sells this Product to dealers and other financial institutions at a discount to the issue price or rebates
to them for their account some proportion of the issue price ("Distribution Fees"). Further information is available on request.
Structured transactions are complex and may involve a high risk of loss. Prior to entering into a transaction you should consult
with your own legal, regulatory, tax, financial and accounting advisors to the extent you consider it necessary, and make your
own investment, hedging and trading decisions (including decisions regarding the suitability of this transaction) based upon your
own judgement and advice from those advisors you consider necessary. Save as otherwise expressly agreed in writing, UBS is not
acting as your financial advisor or fiduciary in any transaction.
This document should not be construed as an offer, personal recommendation or solicitation to conclude a transaction and should
not be treated as giving investment advice. The terms of any investment in the Product to which this document relates will be
exclusively subject to the detailed provisions, including risk considerations, contained in the Product Documentation.
UBS makes no representation or warranty relating to any information herein which is derived from independent sources. This
document shall not be copied or reproduced without UBS's prior written permission.
No action has been or will be taken in any jurisdiction that would permit a public offering of the Products described herein,
save where explicitly stated in the Product Documentation. The Products must be sold in accordance with all applicable selling
restrictions in the jurisdictions in which they are sold.
There is a possibility that costs, including taxes, related to transactions in connection with this Product may arise for Investors that
are not paid by UBS or imposed by it. Please refer to the Product Documentation for further information.

Product Documentation

This document ("Final Terms") contains the final terms for the Product. This document has not been prepared in accordance
with the Swiss Federal Act on Financial Services (FinSA) pursuant to article 35 et seq. FinSA. In this regard, but not limited to,
article 69 FinSA shall not apply to the defined information within this document accordingly.
The Final Terms together with the 'UBS Swiss Base Prospectus for the Issuance of Securities', stipulated in English and as amended
from time to time, ("Base Prospectus") shall form the entire documentation for this Product ("Product Documentation"), and
accordingly the Final Terms should always be read together with the Base Prospectus and any supplements thereto. Definitions
used in the Final Terms, but not defined herein shall have the meaning given to them in the Base Prospectus.
The Product Documentation can be obtained free of charge from UBS AG, P.O. Box, CH-8098 Zurich (Switzerland), via telephone
(+41-(0)44-239 47 03), fax (+41-(0)44-239 69 14) or via e-mail ([email protected]). In addition, for clients outside of
the United Kingdom, the Product Documentation is available at www.ubs.com/keyinvest. Notices in connection with this Product
shall be validly given by publication as described in the Base Prospectus. Furthermore, for clients outside of the United Kingdom,
any changes with regard to the terms of this Product shall be published at www.ubs.com/keyinvest.
Upon the replacement of the Base Prospectus by a successor version of the Base Prospectus the Final Terms are to be read together
with the latest valid successor version of the Base Prospectus (each, a "Successor Base Prospectus") which has succeeded either
(i) the Base Prospectus, or (ii) if one or more Successor Base Prospectuses to the Base Prospectus have already been published,
the most recently published Successor Base Prospectus, and the term "Product Documentation" shall be interpreted accordingly.
The Issuer consents to the use of the Base Prospectus (including any Successor Base Prospectus) together with the relevant Final
Terms in connection with a public offer of the Products by any financial intermediary that is authorised to make such offers.

Selling Restrictions

Any Products purchased by any person for resale may not be offered in any jurisdiction in circumstances which would result in the Issuer being obliged
to register any further documentation relating to this Product in such jurisdiction.
The restrictions listed below must not be taken as definitive guidance as to whether this Product can be sold in a jurisdiction. Additional restrictions
on offering, selling or holding of this Product may apply in other jurisdictions. Investors in this Product should seek specific advice before on-selling
this Product.

Switzerland ­ The offering of the Products in Switzerland is exempt from the requirement to prepare and publish a prospectus pursuant to the Swiss Federal Act on
Financial Services (FinSA). No part of the Product Documentation has been reviewed or approved by or filed with a review body pursuant to article 52 FinSA.
The Products may only be offered, sold or otherwise made available to professional clients as defined in article 4 para. 3 and article 5 of FinSA.


European Economic Area - In relation to each Member State of the European Economic Area (each, a "Member State"), an offer of the Products to the public
in a Member State may only be made in accordance with the following exemptions as set out in the Regulation (EU) 2017/1129 (as may be amended or replaced
from time to time) (the "Prospectus Regulation"):
(a)
Qualified investors: at any time to any legal entity which is a qualified investor as defined in the Prospectus Regulation;
(b)
Fewer than 150 offerees: at any time to fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Regulation);
(c)
An offer of Products addressed to investors who acquire Products for a total consideration of at least EUR 100,000 per investor, for each separate offer; and/or
(d)
Other exempt offers: at any time in any other circumstances falling within Article 1 (4) of the Prospectus Regulation,
Contact:
UBS AG, P.O. Box, 8098 Zürich
Private Investors: Please contact your client advisor or send an email to [email protected]
Internet:
www.ubs.com/keyinvest
Banks and Intermediaries: +41-44-239 76 76*
Investors outside of Switzerland should consult their local client advisors
Please note that calls made to the numbers marked with an asterisk (*) may be recorded. Should you call one of these numbers, we shall assume that you consent to this business practice.



8/8
Valor: 113671875 / ISIN: CH1136718751 / WKN: UH3ENJ / Common Code: 239776477
Final Terms


provided that no such offer of Products referred to in (a) to (d) above shall require the publication of a prospectus pursuant to Article 3 of the Prospectus Regulation,
or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation.
For the purposes of this provision, the expression "offer of Securities to the public" in relation to any Products in any Member State means the communication in
any form and by any means of sufficient information on the terms of the offer and the Products to be offered so as to enable an investor to decide to purchase
or subscribe the Products.



Hong Kong
Each purchaser has represented and agreed that it has not issued or had in its possession for the purposes of issue, and will not issue or have in its possession for the
purposes of issue, whether in Hong Kong or elsewhere, any advertisement, invitation or document relating to the Products, which is directed at, or the contents of
which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to
Products which are or are intended to be disposed of only to persons outside Hong Kong or only to "professional investors" as defined in the Securities and Futures
Ordinance (Cap. 571) of Hong Kong and any rules made under that Ordinance.
This is a structured product which involves derivatives. Do not invest in it unless you fully understand and are willing to assume the risks associated
with it. If you are in any doubt about the risks involved in the product, you may clarify with the intermediary or seek independent professional advice.

Singapore
This document has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this document and any other document or material
in connection with the offer or sale, or invitation for subscription or purchase, of the Products may not be circulated or distributed, nor may the Products be offered
or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional
investor (as defined in Section 4A) under Section 274 of the Securities and Futures Act Chapter 289 of Singapore, as modified and/or amended from time to time (the
"SFA")), (ii) to a relevant person (as defined in Section 275(2) of the SFA) pursuant to Section 275(1), or any person pursuant to Section 275(1A), and in accordance
with the conditions specified in Section 275 of the SFA and (where applicable) Regulation 3 of the Securities and Futures (Classes of Investors) Regulations 2018, or
(iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.
Where the Products are subscribed or purchased under Section 275 of the SFA by a relevant person which is:
(a)
a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share
capital of which is owned by one or more individuals, each of whom is an accredited investor; or
(b)
a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an
accredited investor,
securities or securities-based derivatives contracts (each term as defined in Section 2(1) of the SFA) of that corporation or the beneficiaries' rights and interest
(howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the Products pursuant to an
offer made under Section 275 of the SFA except:
(1)
to an institutional investor or to a relevant person defined in Section 275(2) of the SFA, or to any person arising from an offer referred to in Section 275(1A)
or Section 276(4)(i)(B) of the SFA;
(2)
where no consideration is or will be given for the transfer;
(3)
where the transfer is by operation of law;
(4)
as specified in Section 276(7) of the SFA; or
(5)
as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and Securities-based Derivatives Contracts) Regulations 2018.


Pursuant to section 309B(1)(c) of the SFA, the Issuer hereby notifies the relevant persons (as defined in the SFA) that the Products are classified as "capital markets
products other than prescribed capital markets products" (as defined in the SFA and the Securities and Futures (Capital Markets Products) Regulations 2018) and
"Specified Investment Products" (as defined in the MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on
Recommendations on Investment Products).
UK
For the purpose of non-discretionary accounts, this Product should not be sold with a consideration of less than 100,000 EUR or equivalent.


USA
This Product may not be sold or offered within the United States or to U.S. persons.
Contact:
UBS AG, P.O. Box, 8098 Zürich
Private Investors: Please contact your client advisor or send an email to [email protected]
Internet:
www.ubs.com/keyinvest
Banks and Intermediaries: +41-44-239 76 76*
Investors outside of Switzerland should consult their local client advisors
Please note that calls made to the numbers marked with an asterisk (*) may be recorded. Should you call one of these numbers, we shall assume that you consent to this business practice.


Incorporation by Reference

The Annual Report 2020, the Standalone Financial Statements 2020, the Annual Report 2019, the Standalone
Financial Statements 2019, the UBS Group First Quarter 2021 Report, the UBS AG First Quarter 2021 Report, the
UBS Group Second Quarter 2021 Report, the UBS AG Second Quarter 2021 Report, UBS Swiss Base Prospectus
for the Issuance of Securities dated 1 October 2021, as supplemented from time to time, and the Registration
Document of UBS AG dated 1 October 2021 are fully incorporated in, and form an integral part of, this document.
So long as the Products are listed on the official list of the Luxembourg Stock Exchange, the audited
consolidated and non-consolidated annual financial statements for the years ended 31 December 2020
and 31 December 2019, of the Issuer may be obtained free of charge from the offices of the Lead Manager.
The Issuer publishes unaudited consolidated and non-consolidated quarterly financial statements for the four
three month periods ended 31 March, 30 June, 30 September and 31 December and audited annual
consolidated and non-consolidated financial statements for the years ended 31 December. The future
consolidated and non-consolidated annual audited financial accounts and future consolidated and non-
consolidated quarterly non-audited financial accounts of the Issuer will be available at the offices of the Lead
Manager.
So long as the Certificates are listed on the official list of Luxembourg Stock Exchange, the articles of
association of the Issuer will be available free of charge at the office of Lead Manager.
Any statement contained in this Prospectus or in a document incorporated or deemed incorporated by
reference into this Prospectus will be deemed to be modified or superseded for purposes of this Prospectus to
the extent that a statement contained in any subsequent document modifies or supersedes that statement.
Any statement that is modified or superseded in this manner will no longer be a part of this Prospectus,
except as modified or superseded.

You may request a copy, at no cost, of any or all of the documents that are incorporated by reference into this
Prospectus, excluding exhibits (other than those that we specifically incorporate by reference into the
documents that you request) by contacting UBS AG, orally or in writing, at the following address:

UBS AG
Investor Relations G41B
P.O. Box
CH-8098 Zurich
Switzerland
Phone: +41-44-234 41 00
Fax: +41-44-234 34 15

Documents incorporated by reference and this Prospectus will be also published on the website of the
Luxembourg Stock Exchange (www.bourse.lu).


Document Outline